miR-301a-3p was found significantly upregulated in peripheral blood mononuclear cells (PBMC) from SLE patients, and the increasing miR-301a-3p promoted IFN-gamma, IL-17, and IL-6 expression in PBMC in vivo (67). This evidence concerns the gene IL6 and systemic lupus erythematosus.